These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
347 related articles for article (PubMed ID: 9461198)
41. Clinical implications of the involvement of tPA in neuronal cell death. Tsirka SE J Mol Med (Berl); 1997 May; 75(5):341-7. PubMed ID: 9181475 [TBL] [Abstract][Full Text] [Related]
42. IMM-H004 prevents toxicity induced by delayed treatment of tPA in a rat model of focal cerebral ischemia involving PKA-and PI3K-dependent Akt activation. Zuo W; Chen J; Zhang S; Tang J; Liu H; Zhang D; Chen N Eur J Neurosci; 2014 Jun; 39(12):2107-18. PubMed ID: 24649933 [TBL] [Abstract][Full Text] [Related]
43. Tissue-type plasminogen activator is a neuroprotectant in the mouse hippocampus. Echeverry R; Wu J; Haile WB; Guzman J; Yepes M J Clin Invest; 2010 Jun; 120(6):2194-205. PubMed ID: 20440070 [TBL] [Abstract][Full Text] [Related]
44. The low-density lipoprotein receptor-related protein 1 mediates tissue-type plasminogen activator-induced microglial activation in the ischemic brain. Zhang C; An J; Strickland DK; Yepes M Am J Pathol; 2009 Feb; 174(2):586-94. PubMed ID: 19147818 [TBL] [Abstract][Full Text] [Related]
45. Essential role of endogenous tissue plasminogen activator through matrix metalloproteinase 9 induction and expression on heparin-produced cerebral hemorrhage after cerebral ischemia in mice. Zhao BQ; Ikeda Y; Ihara H; Urano T; Fan W; Mikawa S; Suzuki Y; Kondo K; Sato K; Nagai N; Umemura K Blood; 2004 Apr; 103(7):2610-6. PubMed ID: 14630814 [TBL] [Abstract][Full Text] [Related]
46. Tissue-type plasminogen activator and the low-density lipoprotein receptor-related protein mediate cerebral ischemia-induced nuclear factor-kappaB pathway activation. Zhang X; Polavarapu R; She H; Mao Z; Yepes M Am J Pathol; 2007 Oct; 171(4):1281-90. PubMed ID: 17717150 [TBL] [Abstract][Full Text] [Related]
47. MMP10 Promotes Efficient Thrombolysis After Ischemic Stroke in Mice with Induced Diabetes. Navarro-Oviedo M; Roncal C; Salicio A; Belzunce M; Rabal O; Toledo E; Zandio B; Rodríguez JA; Páramo JA; Muñoz R; Orbe J Transl Stroke Res; 2019 Aug; 10(4):389-401. PubMed ID: 30051168 [TBL] [Abstract][Full Text] [Related]
48. Tissue plasminogen activator extravasated through the cerebral vessels: evaluation using a rat thromboembolic stroke model. Harada T; Kano T; Katayama Y; Matsuzaki T; Tejima E; Koshinaga M Thromb Haemost; 2005 Oct; 94(4):791-6. PubMed ID: 16270632 [TBL] [Abstract][Full Text] [Related]
49. Transient brain hypothermia reduces the reperfusion injury of delayed tissue plasminogen activator and extends its therapeutic time window in a focal embolic stroke model. Zarisfi M; Allahtavakoli F; Hassanipour M; Khaksari M; Rezazadeh H; Allahtavakoli M; Taghavi MM Brain Res Bull; 2017 Sep; 134():85-90. PubMed ID: 28710023 [TBL] [Abstract][Full Text] [Related]
50. Mouse model of microembolic stroke and reperfusion. Atochin DN; Murciano JC; Gürsoy-Ozdemir Y; Krasik T; Noda F; Ayata C; Dunn AK; Moskowitz MA; Huang PL; Muzykantov VR Stroke; 2004 Sep; 35(9):2177-82. PubMed ID: 15256680 [TBL] [Abstract][Full Text] [Related]
51. Involvement of matrix metalloproteinase in thrombolysis-associated hemorrhagic transformation after embolic focal ischemia in rats. Sumii T; Lo EH Stroke; 2002 Mar; 33(3):831-6. PubMed ID: 11872911 [TBL] [Abstract][Full Text] [Related]
52. Lipoprotein receptor-mediated induction of matrix metalloproteinase by tissue plasminogen activator. Wang X; Lee SR; Arai K; Lee SR; Tsuji K; Rebeck GW; Lo EH Nat Med; 2003 Oct; 9(10):1313-7. PubMed ID: 12960961 [TBL] [Abstract][Full Text] [Related]
53. Effects of tissue type plasminogen activator in embolic versus mechanical models of focal cerebral ischemia in rats. Meng W; Wang X; Asahi M; Kano T; Asahi K; Ackerman RH; Lo EH J Cereb Blood Flow Metab; 1999 Dec; 19(12):1316-21. PubMed ID: 10598935 [TBL] [Abstract][Full Text] [Related]
54. Nitric oxide mediates neurodegeneration and breakdown of the blood-brain barrier in tPA-dependent excitotoxic injury in mice. Parathath SR; Parathath S; Tsirka SE J Cell Sci; 2006 Jan; 119(Pt 2):339-49. PubMed ID: 16410551 [TBL] [Abstract][Full Text] [Related]
55. Reduction of hippocampal cell death and proteolytic responses in tissue plasminogen activator knockout mice after transient global cerebral ischemia. Lee SR; Lok J; Rosell A; Kim HY; Murata Y; Atochin D; Huang PL; Wang X; Ayata C; Moskowitz MA; Lo EH Neuroscience; 2007 Nov; 150(1):50-7. PubMed ID: 17936515 [TBL] [Abstract][Full Text] [Related]
57. Tissue-type plasminogen activator in the ischemic brain: more than a thrombolytic. Yepes M; Roussel BD; Ali C; Vivien D Trends Neurosci; 2009 Jan; 32(1):48-55. PubMed ID: 18963068 [TBL] [Abstract][Full Text] [Related]
58. Neuronal degeneration and a decrease in laminin-like immunoreactivity is associated with elevated tissue-type plasminogen activator in the rat hippocampus after kainic acid injection. Nagai N; Urano T; Endo A; Takahashi H; Takada Y; Takada A Neurosci Res; 1999 Feb; 33(2):147-54. PubMed ID: 10211780 [TBL] [Abstract][Full Text] [Related]